ImmunoCellular Therapeutics, Ltd. 4
4 · ImmunoCellular Therapeutics, Ltd. · Filed Mar 10, 2014
Insider Transaction Report
Form 4
FRACTOR DAVID
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2014-03-07+20,000→ 20,000 totalExercise: $1.34Exp: 2024-03-06→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over four years beginning April 7, 2014.